vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and NexPoint Real Estate Finance, Inc. (NREF). Click either name above to swap in a different company.
Gossamer Bio, Inc. is the larger business by last-quarter revenue ($13.8M vs $11.1M, roughly 1.2× NexPoint Real Estate Finance, Inc.). NexPoint Real Estate Finance, Inc. runs the higher net margin — 216.6% vs -342.3%, a 559.0% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs -48.8%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
NexPoint Real Estate Finance, Inc. is a US-based commercial real estate finance firm that offers structured financing solutions for multifamily, office, industrial, and hospitality properties. It focuses on originating, managing and servicing a diversified portfolio of mortgage loans and real estate-related investments to deliver stable risk-adjusted returns to stakeholders.
GOSS vs NREF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $11.1M |
| Net Profit | $-47.2M | $24.0M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | — |
| Net Margin | -342.3% | 216.6% |
| Revenue YoY | 47.1% | -48.8% |
| Net Profit YoY | -43.0% | 58.7% |
| EPS (diluted) | $-0.21 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $11.1M | ||
| Q3 25 | $13.3M | $12.5M | ||
| Q2 25 | — | $12.1M | ||
| Q1 25 | — | $11.5M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | — | $12.5M | ||
| Q2 24 | $95.8M | $6.7M | ||
| Q1 24 | $0 | $-12.8M |
| Q4 25 | $-47.2M | $24.0M | ||
| Q3 25 | $-48.2M | $50.9M | ||
| Q2 25 | — | $22.3M | ||
| Q1 25 | — | $26.0M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | — | $23.3M | ||
| Q2 24 | $49.2M | $12.1M | ||
| Q1 24 | $-41.9M | $-14.6M |
| Q4 25 | -333.6% | — | ||
| Q3 25 | -369.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | -342.3% | 216.6% | ||
| Q3 25 | -362.7% | 407.0% | ||
| Q2 25 | — | 184.5% | ||
| Q1 25 | — | 225.6% | ||
| Q4 24 | — | 69.9% | ||
| Q3 24 | — | 186.4% | ||
| Q2 24 | 51.4% | 179.7% | ||
| Q1 24 | — | 114.3% |
| Q4 25 | $-0.21 | $0.47 | ||
| Q3 25 | $-0.21 | $1.14 | ||
| Q2 25 | — | $0.54 | ||
| Q1 25 | — | $0.70 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | $0.22 | $0.40 | ||
| Q1 24 | $-0.19 | $-0.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $31.1M |
| Total DebtLower is stronger | — | $771.2M |
| Stockholders' EquityBook value | $-122.8M | $388.0M |
| Total Assets | $172.2M | $5.3B |
| Debt / EquityLower = less leverage | — | 1.99× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $31.1M | ||
| Q3 25 | $180.2M | $17.9M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $19.2M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | — | $34.7M | ||
| Q2 24 | $354.5M | $4.3M | ||
| Q1 24 | $244.4M | $13.5M |
| Q4 25 | — | $771.2M | ||
| Q3 25 | — | $720.9M | ||
| Q2 25 | — | $815.6M | ||
| Q1 25 | — | $831.5M | ||
| Q4 24 | — | $799.3M | ||
| Q3 24 | — | $815.5M | ||
| Q2 24 | — | $861.0M | ||
| Q1 24 | — | $843.3M |
| Q4 25 | $-122.8M | $388.0M | ||
| Q3 25 | $-82.3M | $375.4M | ||
| Q2 25 | — | $348.2M | ||
| Q1 25 | — | $343.7M | ||
| Q4 24 | — | $336.5M | ||
| Q3 24 | — | $335.8M | ||
| Q2 24 | $81.5M | $327.5M | ||
| Q1 24 | $26.7M | $327.1M |
| Q4 25 | $172.2M | $5.3B | ||
| Q3 25 | $208.8M | $5.3B | ||
| Q2 25 | — | $5.4B | ||
| Q1 25 | — | $5.4B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | — | $5.7B | ||
| Q2 24 | $373.4M | $6.6B | ||
| Q1 24 | $259.4M | $7.1B |
| Q4 25 | — | 1.99× | ||
| Q3 25 | — | 1.92× | ||
| Q2 25 | — | 2.34× | ||
| Q1 25 | — | 2.42× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 2.63× | ||
| Q1 24 | — | 2.58× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $-4.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $-4.5M | ||
| Q3 25 | $-36.2M | $8.1M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | — | $14.7M | ||
| Q2 24 | $116.3M | $-7.5M | ||
| Q1 24 | $-52.3M | $17.7M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.62× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.63× | ||
| Q2 24 | 2.36× | -0.62× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
